Calidi BiotherapeuticsCLDI
13F holders, Q1 2025 (March 31)36holders +3
8new positions
5sold out
$0.57avg. 13F price*
At the end of Q1 2025, 36 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, up 3 from Q4 2024. 8 opened new positions and 5 sold out. The largest holders were Armistice Capital, LLC ($1.9M), Bank of Montreal ($277K) and Vanguard Group Inc. ($200K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $2.1M |
| Exits | 5 | $237K |
All 13F filers, Q4 2024 → Q1 2025: 4,626,683 shares bought and 270,180 shares sold, net +4,356,503 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| Armistice Capital, LLC | 0.05% | New | 3,322,000 | $1.9M |
| Bank of Montreal | 0.00% | Add +3818.4% | 489,800 | $277K |
| Vanguard Group Inc. | 0.00% | Add +475.8% | 353,380 | $200K |
| Geode Capital Management, LLC | 0.00% | Add +57.4% | 251,916 | $143K |
| Belpointe Asset Management LLC | 0.01% | New | 249,833 | $141K |
| HighTower Advisors, LLC | 0.00% | Add +16.8% | 119,471 | $68K |
| CPR Investments Inc. | 0.05% | No change | 101,000 | $57K |
| Red Wave Investments LLC | 0.02% | No change | 80,828 | $46K |
| State Street Corp. | 0.00% | Add +168.9% | 61,290 | $35K |
| RS Crum Inc. | 0.01% | Add +36.7% | 55,313 | $31K |
| Drive Wealth Management, LLC | 0.01% | Reduce -38.9% | 55,000 | $31K |
| Virtu Financial LLC | 0.00% | Reduce -25.5% | 54,737 | $31K |
| Northern Trust Corp. | 0.00% | Add +144.3% | 48,693 | $28K |
| Susquehanna International Group, LLP | 0.00% | Add +41.9% | 32,642 | $18K |
| Delta Investment Management, LLC | 0.00% | No change | 21,023 | $12K |
| Two Sigma Securities, LLC | 0.00% | New | 20,259 | $11K |
| Osaic Holdings, Inc. | 0.00% | Add +2456.8% | 19,253 | $11K |
| XTX Topco Ltd | 0.00% | New | 16,034 | $9K |
| Commonwealth Equity Services, LLC | 0.00% | New | 13,500 | $8K |
| Highbridge Capital Management LLC | 0.00% | No change | 12,501 | $7K |
| Apollo Management Holdings, L.P. | 0.00% | No change | 12,500 | $7K |
| Finepoint Capital LP | 0.00% | Reduce -0.0% | 12,499 | $7K |
| NewEdge Advisors, LLC | 0.00% | New | 11,000 | $6K |
| Grassi Investment Management | 0.00% | No change | 10,000 | $6K |
| Avidian Wealth Enterprises, LLC | 0.00% | No change | 10,000 | $6K |
| Evermay Wealth Management LLC | 0.00% | No change | 6,342 | $4K |
| Royal Bank of Canada | 0.00% | No change | 5,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 5,116 | $3K |
| Barrett & Company, Inc. | 0.00% | No change | 3,500 | $2K |
| Morgan Stanley | 0.00% | Reduce -19.9% | 2,019 | $1K |
| Tradewinds Capital Management, LLC | 0.00% | No change | 1,000 | $567 |
| CVA Family Office, LLC | 0.00% | No change | 500 | $283 |
| SBI Securities Co., Ltd. | 0.00% | New | 300 | $170 |
| BlackRock, Inc. | 0.00% | No change | 259 | $147 |
| Bank of America Corp. | 0.00% | Reduce -79.0% | 222 | $126 |
| UBS Group AG | 0.00% | Reduce -100.0% | 1 | $1 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.